CompanyDeals

Daxiang Biotech Raises RMB 100M in Pre-Series B Financing for Organoid-on-a-Chip

Company

Harbin Gloria Pharmaceuticals Faces Change in Control Amid Bankruptcy

CompanyDeals

HitGen Partners with Daewoong Pharmaceutical for Drug Discovery

Deals

AstraZeneca and CICC Capital Launch RMB 3 Billion Fund in Hangzhou

CompanyDrug

Henlius Biotech’s BRAF V600E Inhibitor HLX208 Approved for Clinical Study in China

Policy / Regulatory

China Updates Hypertension Guidelines, Lowers Diagnostic Threshold

Company

AstraZeneca Reports 19% YOY Revenue Growth in Q3 2022

CompanyDrug

FDA Approves Phase Ib Study for Jiangsu Yahong’s APL1401 in Ulcerative Colitis

CompanyDeals

Baheal Partners with AstraZeneca for Commercial Rights to Onglyza

Company

EQRx Shifts Strategy Amid FDA Feedback on China-Sourced Data

R&D

Peking University Study Identifies Liver Cancer Immune Microenvironment Subtypes

CompanyDrug

CDE Prioritizes Review for Jiedi Pharma’s Mitotane and Other Key Drugs